For the latest COVID-19 Travel restrictions and recommendations please click here

SMi are proud to present the 8th annual Point of Care Diagnostics: Market Adoption and Technology Trends conference scheduled for the 24th and 25th of October 2011.

The need for point of care diagnostics has rapidly increased in an era of mandatory efficiency. Bypassing pathology laboratories and the integration of software interfaces could redirect resources and support comparatively rapid response and action for the patient. Successful adoption of POCT predicts the amelioration of turnaround time, morbidity and mortality in healthcare. The supply and demand for POCT has never been greater and now possesses the momentum and trajectory to circumvent analytical, regulatory, political and commercial constraints.

Key opinion leaders deliver this case study driven conference, orators will provide insight into contemporary issues and success stories equipping delegates with valuable information essential for success in the global market place.

The conference will address:

  • Technology trends and advances: Presentation and review of the hottest technology of the year
  • Commercial and Regulatory issues: The business case for developing POCT and facilitating the translation of research and gaps in technology
  • Developing, BRIC and developed world market review: Analysis of world market trends and identification of demand and gaps in supply.
  • Oncology, companion diagnostics and personalised medicine: Pharmaceuticals vs. pharmasuitables and prescribing the appropriate treatment to an individual

Current Registered Attendess from the following companies include: Abaxis, Bio Rad Labs, bioMérieux SA. Carclo Technical Plastics, Consort Medical plc, Invetech, Irish Medicines Board, NHS National Innovation Centre, Orion Diagnostica Oy, Qiagen A G, Roche Diagnostics, Sekisui Diagnostics, SPD Development Co LTD, Stratophase Ltd, Systelab Technologies, The Sagentia Group A G, Thinxxs, University Of The West Of England Bristol, Vivacta Ltd & Werfen Group

  • Appreciate a holistic view of the industry from producer to end user
  • Learn about the potential value that POCD confers to industry
  • Benchmark data and protocols with other companies
  • Remove obstacles to market, understand gaps and realise opportunities
  • Network with key opinion leaders
  • Business Development Manager
  • Chief Executive Officer
  • Chief Scientific Officer
  • Commercial Manager
  • Diagnostics Director
  • Director Business Unit Commercial operations
  • Director General
  • Director of Personalized Medicine, OVID
  • Director of Reimbursement - EMEA
  • Director of the Institute of Biotechnology, Professor of Biotechnology
  • Director, Critical Care Analytical
  • Director, Healthcare Industry Solutions, Digital Health Group
  • Director, Product Development
  • Director, R&D
  • Group Managing Director
  • Head of Business Microfluids


  • Head of Microfluidics
  • International Marketing Manager
  • Lead Specialist, Detection and Identification Of Infectious Agents
  • Managing Director
  • Medical Director and Director Medical Affairs
  • Medical Technology Consultant
  • Point of Care Manager
  • Program Manager
  • Regulatory Affairs Manager
  • Scientific Director
  • Senior Director, Translational Oncology Group
  • Senior International Marketing and Business Development Manager
  • Vice President of R&D Worldwide
  • Vice President, Medical & Scientific Affairs
  • Visiting Professor in Clinical Biochemistry
  • VP Market Development, Cardiac Markers


Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

David Huckle

David Huckle, President / Director General, A B A France

9:10 Point of Care Diagnostics – A Leopard Changing its Spots

David Huckle

David Huckle, President / Director General, A B A France

• Global market dynamics & quantification.
• Adoption of POCT – changing acceptance.
• Applications – growing uses & different technologies.
• Healthcare economics impact & changing patient pathway.
• Hurdles remain – regulatory, manufacturing control, political changes, budget changes, cost restraint & Impact on other product areas and healthcare

9:50 POC in the community for hard to reach populations

Devaki Nair

Devaki Nair, Consultant Clinical Pathologist, Royal Free Hospital

• Unique challenges
• Current methods
• What can be done better and more effectively

10:30 Morning Coffee

11:00 Direct to consumer diagnostics

Sarah Johnson

Sarah Johnson, , SPD Development Co LTD

• Size of market
• Specific requirements in designing for tests for the general public
• Case study on development of a new diagnostic

11:40 Non invasive POCT

Richard Gill

Richard Gill, Consultant, Genomic Healthcare Strategies

• NIR technology in the determination of alcohol intoxication
• Confirmation of biometric identity
• Potential use for other drugs of abuse
• Commercialisation of POCT in the workplace, medical, point of sale and automotive
• Overview of Neuropix non invasive scanning laser opthalmoscope to measure B Amyloid in the lens of the eye for Alzheimer’s disease POC Dx

12:20 Networking Lunch

13:50 Pharmasuitables and oncology

Christopher Lowe

Christopher Lowe, Director of the Institute of Biotechnology, Professor of Biotechnology, Cambridge University

• Co-development of Rx-Dx 
• Global needs of personalised oncology medicines
• Adoption and implementation

14:30 Versatile optical detection for POCT

Oliver Hofmann

Oliver Hofmann, Head of Microfluidics, Molecular Vision Ltd.

• Key considerations for optical POCT detection
• Organic semiconductor based light sources and detectors
• Integrated fluorescence detection using low-cost optical filtering approaches
• Application to multiplexed cardiac marker assays

15:10 Afternoon Tea

15:40 Electrochemical biosensors and cancer

Jose Pingarron

Jose Pingarron, Professor of analytical chemistry, Complutense University of Madrid

• Improved early detection
• Nanotechnology and POC sensors
• Biosensors- DNA and immunosensors
• Market opportunities

16:20 Identifying market opportunities

Harry Glorikian

Harry Glorikian, Managing Partner, Scientia Advisors

• Strategies for success in market access
• Core value dossiers, cost-effectiveness and budget impact on de novo arguments
• Evidence based medicine and other critical reimbursement factors

17:00 Chairman’s Closing Remarks and Close of Day One

David Huckle

David Huckle, President / Director General, A B A France

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Chris Price

Chris Price, Visiting Professor in Clinical Biochemistry, University of Oxford

9:10 Health delivery and improvement with POCT

Chris Price

Chris Price, Visiting Professor in Clinical Biochemistry, University of Oxford

• Disruptive innovation, changing the status quo
• Managing long term conditions
• Professional, legal, cultural and other barriers

9:50 Advances in POC nucleic acid testing

John Clarkson

John Clarkson, Chief Executive, ATLAS GENETICS LTD

• Fully integrated and simple to use nucleic acid systems are now available
• New systems in the development pipeline have the potential for POC applications
• Primary application areas include infectious diseases and personalized medicine
• Uptake will be driven on a test by test basis by accuracy, turn-around time, simplicity, throughput and other parameters specific to each application

10:30 Morning Coffee

11:00 Developing Point of Care CD4 tests for low-income countries

Steven Reid

Steven Reid, Programme Manager, Imperial College London

• Particular needs for the low income country market and the impact of POC diagnostics
• Test development in a public/private partnership model: incentives and profit?
• Case study of CD4 for HIV/AIDS
• Measuring impact
• Regulatory and access issues

11:40 Implementation of connectivity solutions for POC

Gillian Hall

Gillian Hall, POCT Coordinator, Royal Free Hospital

• Overview of our POCT devices/locations
• Effective implementation of connectivity solutions
• Regulatory requirements e.g.  CQC, NHLSA, CPA  etc
• How connectivity can help with meeting regulations
• Wish list for future connectivity solutions

12:20 Networking Lunch

13:30 Panel Discussion: Future Developments in POC

• Approaches for proof of mechanism
• Optimising the productivity of clinical trials, proof of concept before commitment
• Facilitating targeted therapy of cancer cells
• The future of oncology

Chris Price

Chris Price, Visiting Professor in Clinical Biochemistry, University of Oxford

Richard Gill

Richard Gill, Consultant, Genomic Healthcare Strategies

14:10 Developments in home testing

Bill Cunningham

Bill Cunningham, Managing Director, CDx

14:50 Afternoon Tea

15:20 Future POC platforms

Penny Wilson

Penny Wilson, Lead Specialist, Detection and Identification Of Infectious Agents, Technology Strategy Board

17:00 Chairman’s Closing Remarks and Close of Day Two

Chris Price

Chris Price, Visiting Professor in Clinical Biochemistry, University of Oxford



Reimbursement, product pricing & procurement

Reimbursement, product pricing & procurement

Copthorne Tara Hotel
26th October 2011
London, United Kingdom

Copthorne Tara Hotel

Scarsdale Place
London W8 5SR
United Kingdom

Copthorne Tara Hotel

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.




speaker image






CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title


Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event


Sign up
Forgotten Password?


UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71

Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out